Literature DB >> 21289408

The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells.

Liang Chen1, Joseph M Mccrate, James C-M Lee, Hao Li.   

Abstract

The objective of this study is to evaluate the effect of hydroxyapatite (HAP) nanoparticles with different surface charges on the cellular uptake behavior and in vitro cell viability and proliferation of MC3T3-E1 cell lines (osteoblast). The nanoparticles' surface charge was varied by surface modification with two carboxylic acids: 12-aminododecanoic acid (positive) and dodecanedioic acid (negative). The untreated HAP nanoparticles and dodecanoic acid modified HAP nanoparticles (neutral) were used as the control. X-ray diffraction (XRD) revealed that surface modifications by the three carboxylic acids did not change the crystal structure of HAP nanoparticles; Fourier transform infrared spectroscopy (FT-IR) confirmed the adsorption and binding of the carboxylic acids on the HAP nanoparticles' surfaces; and zeta potential measurement confirmed that the chemicals successfully modified the surface charge of HAP nanoparticles in water based solution. Transmission electron microscopy (TEM) images showed that positively charged, negatively charged and untreated HAP nanoparticles, with similar size and shape, all penetrated into the cells and cells had more uptake of HAP nanoparticles with positive charge compared to those with negative charge, which might be attributed to the attractive or repulsive interaction between the negatively charged cell membrane and positively/negatively charged HAP nanoparticles. The neutral HAP nanoparticles could not penetrate the cell membrane due to their larger size. MTT assay and LDH assay results indicated that as compared with the polystyrene control, greater cell viability and cell proliferation were measured on MC3T3-E1 cells treated with the three kinds of HAP nanoparticles (neutral, positive, and untreated), among which positively charged HAP nanoparticles showed the strongest improvement for cell viability and cell proliferation. In summary, the surface charge of HAP nanoparticles can be modified to influence the cellular uptake of HAP nanoparticles and the different uptake also influences the behavior of cells. These in vitro results may also provide useful information for investigations of HAP nanoparticle applications in gene delivery and intracellular drug delivery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289408      PMCID: PMC3144725          DOI: 10.1088/0957-4484/22/10/105708

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  37 in total

1.  The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions.

Authors:  Silvia Pezzatini; Raffaella Solito; Lucia Morbidelli; Stefania Lamponi; Elisa Boanini; Adriana Bigi; Marina Ziche
Journal:  J Biomed Mater Res A       Date:  2006-03-01       Impact factor: 4.396

2.  Nano-composite of poly(L-lactide) and surface grafted hydroxyapatite: mechanical properties and biocompatibility.

Authors:  Zhongkui Hong; Peibiao Zhang; Chaoliang He; Xueyu Qiu; Aixue Liu; Li Chen; Xuesi Chen; Xiabin Jing
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

3.  The effect of particle design on cellular internalization pathways.

Authors:  Stephanie E A Gratton; Patricia A Ropp; Patrick D Pohlhaus; J Christopher Luft; Victoria J Madden; Mary E Napier; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

4.  Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging.

Authors:  Yan Guo; Donglu Shi; Jie Lian; Zhongyun Dong; Wei Wang; Hoonsung Cho; Guokui Liu; Lumin Wang; Rodney C Ewing
Journal:  Nanotechnology       Date:  2008-03-25       Impact factor: 3.874

5.  A study on the grafting reaction of isocyanates with hydroxyapatite particles.

Authors:  Q Liu; J R de Wijn; C A van Blitterswijk
Journal:  J Biomed Mater Res       Date:  1998-06-05

6.  Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization.

Authors:  N Rameshbabu; T S Sampath Kumar; T G Prabhakar; V S Sastry; K V G K Murty; K Prasad Rao
Journal:  J Biomed Mater Res A       Date:  2007-03-01       Impact factor: 4.396

7.  Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.

Authors:  Piaoping Yang; Zewei Quan; Lanlan Lu; Shanshan Huang; Jun Lin
Journal:  Biomaterials       Date:  2007-11-08       Impact factor: 12.479

8.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.

Authors:  Sarbari Acharya; Fahima Dilnawaz; Sanjeeb K Sahoo
Journal:  Biomaterials       Date:  2009-07-23       Impact factor: 12.479

9.  Coupling of therapeutic molecules onto surface modified coralline hydroxyapatite.

Authors:  R Murugan; S Ramakrishna
Journal:  Biomaterials       Date:  2004-07       Impact factor: 12.479

10.  In vitro study on different cell response to spherical hydroxyapatite nanoparticles.

Authors:  Mohamed N Rahaman
Journal:  J Biomater Appl       Date:  2008-01-14       Impact factor: 2.646

View more
  65 in total

1.  Biocompatibility of bio based calcium carbonate nanocrystals aragonite polymorph on NIH 3T3 fibroblast cell line.

Authors:  Abdullahi Shafiu Kamba; Maznah Ismail; Tengku Azmi Tengku Ibrahim; Zuki Abu Bakar Zakaria
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

2.  Low temperature aqueous precipitation of needle-like nanophase hydroxyapatite.

Authors:  Sophie C Cox; Parastoo Jamshidi; Liam M Grover; Kajal K Mallick
Journal:  J Mater Sci Mater Med       Date:  2013-09-05       Impact factor: 3.896

3.  Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy.

Authors:  Joung-Pyo Nam; Kihoon Nam; Simhyun Jung; Jae-Woon Nah; Sung Wan Kim
Journal:  J Control Release       Date:  2015-04-30       Impact factor: 9.776

4.  TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Authors:  Dylan K McDaniel; Ami Jo; Veronica M Ringel-Scaia; Sheryl Coutermarsh-Ott; Daniel E Rothschild; Michael D Powell; Rui Zhang; Timothy E Long; Kenneth J Oestreich; Judy S Riffle; Richey M Davis; Irving C Allen
Journal:  Nanomedicine       Date:  2016-12-29       Impact factor: 5.307

5.  Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.

Authors:  N Hassler; S Gamsjaeger; B Hofstetter; W Brozek; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2014-10-15       Impact factor: 4.507

6.  Enhancing Intracranial Delivery of Clinically Relevant Non-viral Gene Vectors.

Authors:  Sneha Berry; Panagiotis Mastorakos; Clark Zhang; Eric Song; Himat Patel; Jung Soo Suk; Justin Hanes
Journal:  RSC Adv       Date:  2016-04-19       Impact factor: 3.361

7.  Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant.

Authors:  Qihui Fan; Yi E Wang; Xinxin Zhao; Joachim S C Loo; Yi Y Zuo
Journal:  ACS Nano       Date:  2011-07-20       Impact factor: 15.881

Review 8.  Phototriggered Drug Delivery Using Inorganic Nanomaterials.

Authors:  Qian Liu; Changyou Zhan; Daniel S Kohane
Journal:  Bioconjug Chem       Date:  2016-10-07       Impact factor: 4.774

9.  Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients.

Authors:  S Gamsjaeger; B Hofstetter; E Zwettler; R Recker; J A Gasser; E F Eriksen; K Klaushofer; E P Paschalis
Journal:  Osteoporos Int       Date:  2012-11-15       Impact factor: 4.507

10.  Antimicrobial activity and biologic potential of silver-substituted calcium phosphate constructs produced with self-propagating high-temperature synthesis.

Authors:  N L Vollmer; J R Spear; R A Ayers
Journal:  J Mater Sci Mater Med       Date:  2016-04-19       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.